Celapram

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CELAPRAM contains the active ingredient citalopram hydrobromide

Continue reading »

Opdivo

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OPDIVO CMI _V17.0 (op-DEE-voh) Nivolumab (nee-vol-u-mab) Consumer

Continue reading »